CVS Caremark posts higher profit, helped by flu season, generics
NEW YORK May 1 (Reuters) - CVS Caremark Corp posted higher quarterly profit on Wednesday, as a more severe cold and flu season boosted sales and more new generic drugs hit the market.
CVS said net income rose to $956 million, or 77 cents per share, in the quarter ended March 31, from $776 million, or 59 cents, a year earlier.
Revenue in the pharmacy benefits management (PBM) unit, which administers drug benefits for employers and health plans and runs a large mail order pharmacy, rose 0.1 percent to $18.31 billion. Revenue in the retail division rose 0.2 percent to $10.05 billion.
Overall revenue slipped 0.1 percent to $30.76 billion in the quarter, but was above the $30.36 billion that Wall Street expected, according to Thomson Reuters I/B/E/S.
- Malaysia says no evidence missing plane flew hours after losing contact |
- Russia holds war games near Ukraine; Merkel warns of catastrophe |
- Rescuers search site of NY building collapse; seven dead
- White House tried to mediate dispute between Senate, CIA panel: source
- Missing jet may have strayed to west, Malaysia military says |